Eli Lilly and Company today announced positive topline results from the landmark TOGETHER-PsO open-label Phase 3b clinical trial evaluating the concomitant use of Taltz (ixekizumab) and Zepbound ...
"The next day, my son convinced me to go to a walk-in clinic. They ran some tests and immediately sent me to the ER. I had ...
IEEE Spectrum on MSN
Tomorrow’s smart pills will deliver drugs and take biopsies
Ingestible electronics can sense and act inside the gut ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results